Clinical Trials Browser

Phase 3 × Liver Neoplasms × lenvatinib × Clear all

NCT05301842 2025-01-15

EMERALD-3

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms